Track CBD Life Sciences Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

CBD Life Sciences Inc. CBDL · Stock Open CBD Life Sciences Inc. in new tab

0.000100 USD
P/B
0.15
ROE
-8.71
Beta
78.81
Loading chart...
Key Metrics
Book Value0.00
Price to Book0.15
Growth
Revenue Growth1.44%

DCF valuation

Model fair value for CBD Life Sciences Inc. (CBDL)
Result
Sign in to run the valuation for CBDL.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–

CBD Life Sciences Inc. Logo CBD Life Sciences Inc. Analysis (CBDL)

United States Health Care Official Website Stock

Is CBD Life Sciences Inc. a good investment? CBD Life Sciences Inc. (CBDL) is currently trading at 0.000100 USD.

Investor FAQ

Does CBD Life Sciences Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is CBD Life Sciences Inc.?

CBD Life Sciences Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

Company Profile

CBD Life Sciences Inc. engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, coffee, wine, skincare line, tablets, and a line of pet products. CBD Life Sciences Inc. formerly known as Optium Cyber Systems, Inc. and Optium Cyber Systems, Inc. changed its name as CBD Life Sciences Inc. in January 2019. The company is based in Scottsdale, Arizona.

Exchange Ticker
PNK (United States) CBDL
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
Jan. 16, 2014 Needs review
May 3, 2018 Needs review
Feb. 5, 2019 1:100
April 22, 2024 Needs review
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion